1,096
Views
230
CrossRef citations to date
0
Altmetric
Reviews

Ligand efficiency indices for effective drug discovery

Pages 469-488 | Published online: 14 May 2007
 

Abstract

Successful drug discovery requires the optimization of a large number of variables ranging from strictly physicochemical parameters such as molecular weight to more complex parameters related to toxicity and bioavailability. Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclinical characterization. However, critical biological issues along the path to the market have diminished the impact and power of this methodology. The physicochemical properties of the novel chemical entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate. The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process. More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be discussed in the broader context. Preliminary results and trends obtained using ligand efficiencies as guides are reviewed and their future application to guide drug discovery will be discussed, as well as their integration into the structure-based drug design methods to make them more effective and numerically robust.

Acknowledgements

The author would like to thank S Muchmore and S Brown for the plot of the theoretical versus experimental Ki values of PTP1B included in . The author also wishes to acknowledge discussions and critical reading of earlier versions of the manuscript by J Greer, P Hajduk, CT Lin, K Longenecker, Y Martin, J Metz, G Stamper, K Stewart, V Stoll, B Szczepankiewicz, TW Von Geldern, H Zhao and I Akritopoulou-Zanze. The suggestions of the referees to improve the manuscript are also appreciated.

Notes

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.